Edition:
United Kingdom

American Renal Associates Holdings Inc (ARA.N)

ARA.N on New York Stock Exchange

20.11USD
21 Sep 2018
Change (% chg)

$-0.68 (-3.27%)
Prev Close
$20.79
Open
$20.78
Day's High
$20.78
Day's Low
$20.00
Volume
189,792
Avg. Vol
39,413
52-wk High
$24.02
52-wk Low
$9.91

Latest Key Developments (Source: Significant Developments)

American Renal Associates Holdings Announces Second Quarter 2018 Results
Tuesday, 7 Aug 2018 

Aug 7 (Reuters) - American Renal Associates Holdings Inc ::AMERICAN RENAL ASSOCIATES HOLDINGS, INC. ANNOUNCES SECOND QUARTER 2018 RESULTS.Q2 ADJUSTED EARNINGS PER SHARE $0.20.Q2 EARNINGS PER SHARE VIEW $0.17 -- THOMSON REUTERS I/B/E/S.QUARTERLY NET PATIENT SERVICE OPERATING REVENUES INCREASED 16.8% TO $217.2 MILLION.SAYS REITERATING ITS GUIDANCE FOR 2018 ADJUSTED EBITDA-NCI TO BE IN A RANGE OF $105 MILLION TO $111 MILLION.  Full Article

American Renal Associates Holdings, Inc. Announces Chief Financial Officer Transition
Thursday, 26 Jul 2018 

American Renal Associates Holdings Inc ::SAYS JASON BOUCHER APPOINTED CFO.AMERICAN RENAL ASSOCIATES HOLDINGS, INC. ANNOUNCES CHIEF FINANCIAL OFFICER TRANSITION.BOUCHER WILL SUCCEED JONATHAN WILCOX, WHO WILL BE LEAVING ON SEPTEMBER 30, 2018.AMERICAN RENAL ASSOCIATES HOLDINGS - REITERATING ITS RECENTLY UPDATED GUIDANCE FOR 2018 ADJUSTED EBITDA-NCI TO BE IN A RANGE OF $105 MILLION TO $111 MILLION.  Full Article

American Renal Associates Holdings Announces Launch Of Secondary Public Offering Of Common Stock
Monday, 26 Mar 2018 

March 26 (Reuters) - American Renal Associates Holdings Inc ::AMERICAN RENAL ASSOCIATES HOLDINGS, INC. ANNOUNCES LAUNCH OF SECONDARY PUBLIC OFFERING OF COMMON STOCK.AMERICAN RENAL ASSOCIATES - LAUNCHES PUBLIC OFFERING OF 5 MILLION SHARES OF COMMON STOCK BY CERTAIN STOCKHOLDERS.AMERICAN RENAL ASSOCIATES - SELLING STOCKHOLDERS, INCLUDES CENTERBRIDGE CAPITAL PARTNERS LP & CERTAIN OF ITS AFFILIATES.  Full Article

American Renal Associates Holdings reports adj. EPS $0.19
Tuesday, 14 Nov 2017 

Nov 14 (Reuters) - American Renal Associates Holdings Inc :Announces third quarter 2017 results.Q3 adjusted earnings per share $0.19.Q3 earnings per share view $0.16 -- Thomson Reuters I/B/E/S.Qtrly ‍net patient service operating revenues decreased 2.7 pct to $187.7 million​.‍Reiterating its prior guidance for 2017 adjusted EBITDA less NCI to be in a range of $100 million and $106 million​.‍Company is reiterating its prior guidance for 2017 adjusted EBITDA less NCI to be in a range of $100 million and $106 million​.  Full Article